Of 59 clinical isolates of Staphylococcus lugdunensis, 76% were P-lactamase negative, with penicillin G MICs of <0.13 ,ug/ml, and 24% were 3-lactamase positive, with penicillin MICs of .-0.5 gg/ml. Bimodal distributions were observed also with ampiciRin, ampiciUin-sulbactam, and amoxicillin-clavulanate. AU strains were susceptible to oxacilin, cephalothin, gentamicin, rifampin, and vancomycin; 98% were erythromycin susceptible.
Staphylococcus lugdunensis is a recently described species characterized by production of fibrinogen affinity factor and ornithine decarboxylase. Freney et al. (3) reported 11 strains from human clinical specimens. Subsequently, the clinical syndromes for 45 isolates (representing 13 patients) were described (2). These syndromes included infective endocarditis, septicemia, deep tissue infection, vascular prosthesis infection, osteomyelitis, and skin infection (2 Clinical Laboratory Standards microdilution method (4).
MICs for ,-lactamase-positive and P-lactamase-negative strains are shown in Fig. 1 . ,B-Lactamase production defined a bimodal distribution for penicillin G. The MIC of penicillin G for ,-lactamase-negative strains of S. lugdunensis was 0.13 ,ug/ml, whereas that for P-lactamase-negative strains of S. aureus was s0.06 jig/ml (1). Ampicillin, amoxicillinclavulanate, and ampicillin-sulbactam MICs were higher for 3-lactamase-positive strains than for P-lactamase-negative 
